Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Primary Care Rx Market Offers Second-Rate Return On Investment, Bristol Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The sales and marketing investment required to compete in the primary care market means that no drug company can perform well by remaining in the category, CFO Bonfield asserts. To maintain a presence in primary care, Bristol will increasingly turn to development partners, as it did to Merck for its dual PPAR agonist muraglitazar.

You may also be interested in...



Primary Care Sales Force Downsizing Will Continue, Bristol Says

Bristol-Myers Squibb expects additional downsizing of its primary care sales force as it shifts its product portfolio to specialty care, Exec VP Donald Hayden told analysts July 29

Primary Care Sales Force Downsizing Will Continue, Bristol Says

Bristol-Myers Squibb expects additional downsizing of its primary care sales force as it shifts its product portfolio to specialty care, Exec VP Donald Hayden told analysts July 29

Rx Marketing Compliance Easier On Specialty Care Marketers, Bristol Exec Says

Compliance with the HHS Office of Inspector General marketing guidelines is made easier by operating outside the highly competitive primary care market, Bristol-Myers Squibb CFO Andrew Bonfield said

Related Content

Topics

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel